ArticleCancers2024

A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.

Sedat Yildirim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.